Search Page

1

Cite

Share

Emerging role of thalidomide in the treatment of gastrointestinal bleeding.

McFarlane M, O'Flynn L, Ventre R, Disney BR. McFarlane M, et al. Among authors: o flynn l. Frontline Gastroenterol. 2018 Apr;9(2):98-104. doi: 10.1136/flgastro-2017-100870. Epub 2017 Nov 2. Frontline Gastroenterol. 2018. PMID: 29588836 Free PMC article. Review.

Cite

Share

2

Cite

Share

Effect of inflammatory bowel disease treatments on patients with diabetes mellitus.

Bower JAJ, O'Flynn L, Kakad R, Aldulaimi D. Bower JAJ, et al. Among authors: o flynn l. World J Diabetes. 2021 Aug 15;12(8):1248-1254. doi: 10.4239/wjd.v12.i8.1248. World J Diabetes. 2021. PMID: 34512890 Free PMC article. Review.

Cite

Share

3

Cite

Share

Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion.

Loftus PG, Watson L, Deedigan LM, Camarillo-Retamosa E, Dwyer RM, O'Flynn L, Alagesan S, Griffin M, O'Brien T, Kerin MJ, Elliman SJ, Barkley LR. Loftus PG, et al. Among authors: o flynn l. Int J Cancer. 2021 Mar 1;148(5):1245-1259. doi: 10.1002/ijc.33383. Epub 2020 Dec 2. Int J Cancer. 2021. PMID: 33152121 Free PMC article.

Cite

Share

4

Cite

Share

Corneal Immunosuppressive Mechanisms, Anterior Chamber-Associated Immune Deviation (ACAID) and Their Role in Allograft Rejection.

Treacy O, Fahy G, Ritter T, O'Flynn L. Treacy O, et al. Among authors: o flynn l. Methods Mol Biol. 2016;1371:205-14. doi: 10.1007/978-1-4939-3139-2_13. Methods Mol Biol. 2016. PMID: 26530803 Review.

Cite

Share

5

Cite

Share

Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice.

Pappritz K, Dong F, Miteva K, Kovacs A, El-Shafeey M, Kerim B, O'Flynn L, Elliman SJ, O'Brien T, Hamdani N, Tschöpe C, Van Linthout S. Pappritz K, et al. Among authors: o flynn l. Front Cardiovasc Med. 2021 May 21;8:632728. doi: 10.3389/fcvm.2021.632728. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34095245 Free PMC article.

Cite

Share

6

Cite

Share

MALDI-IMS as a Tool to Determine the Myocardial Response to Syndecan-2-Selected Mesenchymal Stromal Cell Application in an Experimental Model of Diabetic Cardiomyopathy.

Pappritz K, Klein O, Dong F, Hamdani N, Kovacs A, O'Flynn L, Elliman S, O'Brien T, Tschöpe C, Van Linthout S. Pappritz K, et al. Among authors: o flynn l. Proteomics Clin Appl. 2021 Jan;15(1):e2000050. doi: 10.1002/prca.202000050. Epub 2020 Dec 10. Proteomics Clin Appl. 2021. PMID: 33068073

Cite

Share

7

Cite

Share

Letters.

Bliss MR, O'Flynn L, Sperring B. Bliss MR, et al. Among authors: o flynn l. J Wound Care. 1997 May 2;6(5):248-249. doi: 10.12968/jowc.1997.6.5.248. J Wound Care. 1997. PMID: 27937749

Cite

Share

8

Cite

Share

Immunogenicity of allogeneic mesenchymal stem cells.

Schu S, Nosov M, O'Flynn L, Shaw G, Treacy O, Barry F, Murphy M, O'Brien T, Ritter T. Schu S, et al. Among authors: o flynn l. J Cell Mol Med. 2012 Sep;16(9):2094-103. doi: 10.1111/j.1582-4934.2011.01509.x. J Cell Mol Med. 2012. PMID: 22151542 Free PMC article.

Cite

Share

9

Cite

Share

Administration of Human Non-Diabetic Mesenchymal Stromal Cells to a Murine Model of Diabetic Fracture Repair: A Pilot Study.

Watson L, Chen XZ, Ryan AE, Fleming Á, Carbin A, O'Flynn L, Loftus PG, Horan E, Connolly D, McDonnell P, McNamara LM, O'Brien T, Coleman CM. Watson L, et al. Among authors: o flynn l. Cells. 2020 Jun 3;9(6):1394. doi: 10.3390/cells9061394. Cells. 2020. PMID: 32503335 Free PMC article.

Cite

Share

10

Cite

Share

Umbilical cord-derived CD362⁺ mesenchymal stromal cells for E. coli pneumonia: impact of dose regimen, passage, cryopreservation, and antibiotic therapy.

Horie S, Masterson C, Brady J, Loftus P, Horan E, O'Flynn L, Elliman S, Barry F, O'Brien T, Laffey JG, O'Toole D. Horie S, et al. Among authors: o flynn l. Stem Cell Res Ther. 2020 Mar 13;11(1):116. doi: 10.1186/s13287-020-01624-8. Stem Cell Res Ther. 2020. PMID: 32169108 Free PMC article.

Cite

Share